Troy Wichterman Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Troy Wichterman is Chief Financial Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 184,186 shares of BLFS, which is worth approximately $4.9 Million. The most recent transaction as insider was on Feb 21, 2024, when has been sold 97 shares (Common Stock) at a price of $17.35 per share, resulting in proceeds of $1,682. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 184K
1.34% 3M change
48.07% 12M change
Total Value Held $4.9 Million

Troy Wichterman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2024
SELL
Open market or private sale
$1,682 $17.35 p/Share
97 Reduced 0.15%
64,823 Common Stock
Jan 19 2024
SELL
Open market or private sale
$40,542 $16.76 p/Share
2,419 Reduced 3.59%
64,920 Common Stock
Dec 22 2023
SELL
Open market or private sale
$5,272 $16.79 p/Share
314 Reduced 0.46%
67,339 Common Stock
Dec 17 2023
BUY
Grant, award, or other acquisition
-
254 Added 0.38%
67,366 Common Stock
Dec 03 2023
BUY
Grant, award, or other acquisition
-
287 Added 0.42%
67,653 Common Stock
Dec 01 2023
SELL
Open market or private sale
$8,238 $12.37 p/Share
666 Reduced 0.98%
67,112 Common Stock
Nov 19 2023
BUY
Grant, award, or other acquisition
-
298 Added 0.44%
67,778 Common Stock
Nov 13 2023
SELL
Open market or private sale
$1,034 $10.66 p/Share
97 Reduced 0.14%
67,480 Common Stock
Nov 05 2023
BUY
Grant, award, or other acquisition
-
333 Added 0.49%
67,577 Common Stock
Oct 22 2023
BUY
Grant, award, or other acquisition
-
373 Added 0.55%
67,244 Common Stock
Oct 08 2023
BUY
Grant, award, or other acquisition
-
281 Added 0.42%
66,871 Common Stock
Sep 24 2023
BUY
Grant, award, or other acquisition
-
290 Added 0.43%
66,590 Common Stock
Sep 21 2023
SELL
Open market or private sale
$6,845 $12.7 p/Share
539 Reduced 0.81%
66,300 Common Stock
Sep 10 2023
BUY
Grant, award, or other acquisition
-
408 Added 0.61%
66,839 Common Stock
Aug 27 2023
BUY
Grant, award, or other acquisition
-
498 Added 0.74%
66,431 Common Stock
Aug 25 2023
SELL
Open market or private sale
$6,429 $10.99 p/Share
585 Reduced 0.88%
65,933 Common Stock
Aug 14 2023
SELL
Open market or private sale
$1,181 $12.57 p/Share
94 Reduced 0.14%
66,518 Common Stock
Jun 22 2023
SELL
Open market or private sale
$12,664 $23.41 p/Share
541 Reduced 0.81%
66,612 Common Stock
May 31 2023
SELL
Open market or private sale
$12,997 $23.21 p/Share
560 Reduced 0.83%
67,153 Common Stock
May 16 2023
SELL
Open market or private sale
$2,659 $19.41 p/Share
137 Reduced 0.2%
67,713 Common Stock
Mar 22 2023
SELL
Open market or private sale
$6,770 $21.84 p/Share
310 Reduced 0.45%
67,850 Common Stock
Mar 20 2023
SELL
Open market or private sale
$206,400 $20.64 p/Share
10,000 Reduced 12.79%
68,160 Common Stock
Mar 20 2023
BUY
Exercise of conversion of derivative security
$1,932 $2.06 p/Share
938 Added 1.19%
78,160 Common Stock
Mar 07 2023
SELL
Open market or private sale
$711 $22.95 p/Share
31 Reduced 0.04%
77,222 Common Stock
Mar 01 2023
SELL
Open market or private sale
$35,854 $22.75 p/Share
1,576 Reduced 2.0%
77,253 Common Stock
TW

Troy Wichterman

Chief Financial Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS